Citations

Citations to this article as recorded by  

• Quercus infectoria galls mitigates colitis in mice through alleviating mucosal barrier impairment and suppressing inflammatory factors
  Yan Ding, Jiao-Jiao Bai, Sabahat Ablimit, Muyassar Yasen, Arfidin Anwar, Kudelaidi Kuerban, Mubarak Iminjan, Guo-Qiang Zhang
  Journal of Ethnopharmacology.2025; 343: 119487.     CrossRef
• Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data
  Katsuyoshi Matsuoka, Satoshi Motoya, Takayuki Yamamoto, Minoru Matsuura, Toshimitsu Fujii, Shinichiro Shinzaki, Yohei Mikami, Shoko Arai, Junichi Oshima, Yutaka Endo, Hirotoshi Yuasa, Masato Hoshi, Keiko Sato, Tadakazu Hisamatsu
  Journal of Gastroenterology.2025;[Epub]     CrossRef
• Efficacy and safety of filgotinib for ulcerative colitis: A real‐world multicenter retrospective study in Japan
  Shintaro Akiyama, Kaoru Yokoyama, Soichi Yagi, Shinichiro Shinzaki, Kozo Tsuruta, Shinichiro Yoshioka, Minako Sako, Hiromichi Shimizu, Mariko Kobayashi, Toshiyuki Sakurai, Kei Nomura, Tomoyoshi Shibuya, Masahiro Takahara, Sakiko Hiraoka, Kyohei Sugai, Shu
  Alimentary Pharmacology & Therapeutics.2024; 59(11): 1413.     CrossRef
• Real-World Data on the Effectiveness and Safety of Filgotinib for Ulcerative Colitis in Japanese Patients: A Single-Center Experience
  Takahito Toba, Ryo Karashima, Kodai Fujii, Keiichi Inoue, Nanako Inoue, Yurie Ogawa, Aya Hojo, Ai Fujimoto, Takahisa Matsuda
  Cureus.2024;[Epub]     CrossRef
• Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
  Hyuk Yoon, Byong Duk Ye, Sang-Bum Kang, Kang-Moon Lee, Chang Hwan Choi, Joo-young Jo, Juwon Woo, Jae Hee Cheon
  BMC Gastroenterology.2024;[Epub]     CrossRef
• Patients’ Preference on Advanced Therapy and Follow-Up Procedure for Inflammatory Bowel Disease in Japan: A Web-Based 3A Survey
  Toshifumi Morishita, Shunichi Yanai, Yosuke Toya, Takayuki Matsumoto
  Inflammatory Intestinal Diseases.2024; 9(1): 174.     CrossRef
• The role and prospect of tofacitinib in patients with ulcerative colitis
  Jun Lee
  Intestinal Research.2023; 21(1): 168.     CrossRef
• Advances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitors
  Alexander Goetsch, Ferdinando D’Amico, Mariangela Allocca, Gionata Fiorino, Federica Furfaro, Alessandra Zilli, Tommaso Lorenzo Parigi, Simona Radice, Laurent Peyrin-Biroulet, Silvio Danese
  Expert Opinion on Pharmacotherapy.2023; 24(7): 849.     CrossRef
• Understanding the efficacy of individual Janus kinase inhibitors in the treatment of ulcerative colitis for future positioning in inflammatory bowel disease treatment
  Hiroshi Nakase
  Immunological Medicine.2023; 46(3): 121.     CrossRef
• Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy
  Olga Maria Nardone, Irene Zammarchi, Giovanni Santacroce, Subrata Ghosh, Marietta Iacucci
  Cancers.2023; 15(8): 2389.     CrossRef
• Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review
  Alessandro Massano, Luisa Bertin, Fabiana Zingone, Andrea Buda, Pierfrancesco Visaggi, Lorenzo Bertani, Nicola de Bortoli, Matteo Fassan, Marco Scarpa, Cesare Ruffolo, Imerio Angriman, Cristina Bezzio, Valentina Casini, Davide Giuseppe Ribaldone, Edoardo
  Cancers.2023; 15(15): 3824.     CrossRef
• Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE
  Stefan Schreiber, Gerhard Rogler, Mamoru Watanabe, Séverine Vermeire, Christian Maaser, Silvio Danese, Margaux Faes, Paul Van Hoek, Jeremy Hsieh, Ulrik Moerch, Yan Zhou, Angela de Haas, Christine Rudolph, Alessandra Oortwijn, Edward V. Loftus
  Alimentary Pharmacology & Therapeutics.2023; 58(9): 874.     CrossRef
• Recent advances in anti-inflammatory active components and action mechanisms of natural medicines
  Zhimin Wu, Tao Zhang, Xiaofei Ma, Shuai Guo, Qingqing Zhou, Arshad Zahoor, Ganzhen Deng
  Inflammopharmacology.2023; 31(6): 2901.     CrossRef
• Filgotinib for moderately to severely active ulcerative colitis
  Alessandro Mannucci, Ferdinando D’Amico, Ahmad El Saadi, Laurent Peyrin-Biroulet, Silvio Danese
  Expert Review of Gastroenterology & Hepatology.2022; 16(10): 927.     CrossRef

Citations

Citations to this article as recorded by  

• Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel Disease
  Sunil Samnani, Emily C L Wong, Hasan Hamam, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula
  Journal of Crohn's and Colitis.2025;[Epub]     CrossRef
• Intestinal ultrasound accurately predicts future therapy failure in Crohn’s disease patients in a biologics-induced remission
  Ahmad Albshesh, Alon Abend, Reuma Margalit Yehuda, Hussein Mahajna, Bella Ungar, Shomron Ben-Horin, Uri Kopylov, Dan Carter
  European Journal of Gastroenterology & Hepatology.2025; 37(2): 184.     CrossRef
• Small bowel vasculitis? what a gastroenterologist should know - from diagnosis to management
  João Carlos Gonçalves, Bruno Rosa, José Cotter
  Current Opinion in Gastroenterology.2025; 41(3): 132.     CrossRef
• Leucine-rich alpha-2 glycoprotein as a superior biomarker to C-reactive protein for detecting small bowel lesions in Crohn’s disease
  Masashi Ohno, Atsushi Nishida, Akinori Otsuki, Yoshihiro Yokota, Takayuki Imai, Shigeki Bamba, Osamu Inatomi
  World Journal of Gastrointestinal Endoscopy.2025;[Epub]     CrossRef
• Guidelines for endoscopic diagnosis and treatment of inflammatory bowel diseases
  Takayuki Matsumoto, Tadakazu Hisamatsu, Motohiro Esaki, Teppei Omori, Hirotake Sakuraba, Shinichiro Shinzaki, Ken Sugimoto, Kento Takenaka, Makoto Naganuma, Shigeki Bamba, Takashi Hisabe, Sakiko Hiraoka, Mikihiro Fujiya, Minoru Matsuura, Shunichi Yanai, K
  Digestive Endoscopy.2025; 37(4): 319.     CrossRef
• Role of noncontrast enhanced abdominal ultrasound in the diagnostic assessment of pediatric inflammatory bowel disease
  Katie Ritchie, Angharad Vernon‐Roberts, Andrew S. Day
  Journal of Pediatric Gastroenterology and Nutrition.2025; 80(6): 979.     CrossRef
• Comparison of an Endoscopic Scoring System and the Simplified Magnetic Resonance Index of Activity in Patients with Small Bowel Crohn’s Disease
  Ji Eun Na, Hon Soul Kim, Sung Noh Hong, Kyoung Doo Song, Ji Eun Kim, Eun Ran Kim, Young-Ho Kim, Dong Kyung Chang
  Gut and Liver.2024; 18(1): 97.     CrossRef
• Use of double-balloon endoscopy and an endoscopic scoring system to assess endoscopic remission in isolated small bowel Crohn’s disease after treatment with infliximab
  Wei Han, Jing Hu, Juan Wu, Peipei Zhang, Qiuyuan Liu, Naizhong Hu, Qiao Mei
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease
  Seung Yong Shin, Young Kim, Won-Seok Kim, Jung Min Moon, Kang-Moon Lee, Sung-Ae Jung, Hyesook Park, Eun Young Huh, Byung Chang Kim, Soo Chan Lee, Chang Hwan Choi
  Intestinal Research.2023; 21(1): 148.     CrossRef
• Impact of Crohn’s Disease on the Survival of Patients with Small-Bowel Adenocarcinoma in Korea: A Bicenter Cohort Study
  Kyuwon Kim, Kookhwan Choi, Sung Wook Hwang, Jong Pil Im, Byong Duk Ye, Joo Sung Kim, Kyu Joo Park, Suk-Kyun Yang, Seong-Joon Koh, Sang Hyoung Park
  Gut and Liver.2023; 17(4): 581.     CrossRef
• Diagnosis of Crohn’s disease and ulcerative colitis using the microbiome
  Da-Yeon Kang, Jong-Lyul Park, Min-Kyung Yeo, Sang-Bum Kang, Jin-Man Kim, Ju Seok Kim, Seon-Young Kim
  BMC Microbiology.2023;[Epub]     CrossRef
• Combined Endoscopic and Radiologic Healing Is Associated With a Better Prognosis Than Endoscopic Healing Only in Patients With Crohn's Disease Receiving Anti-TNF Therapy
  Kyunghwan Oh, Eun Hye Oh, Soo Min Noh, Seong Ho Park, Nayoung Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
  Clinical and Translational Gastroenterology.2022; 13(1): e00442.     CrossRef
• Clinical factors to predict flare-up in patients with inflammatory bowel disease during international air travel: A prospective study
  Jihye Park, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Alaa El-Hussuna
  PLOS ONE.2022; 17(1): e0262571.     CrossRef
• Long-term Disease Course of Crohn’s Disease: Changes in Disease Location, Phenotype, Activities, and Predictive Factors
  Choong Wui Cho, Myung-Won You, Chi Hyuk Oh, Chang Kyun Lee, Sung Kyoung Moon
  Gut and Liver.2022; 16(2): 157.     CrossRef
• Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn’s disease in patients with prior failure of anti-tumour necrosis factor treatment
  Hye Kyung Hyun, Hyun-Soo Zhang, Jongwook Yu, Eun Ae Kang, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Is radiological healing alone enough? ‘Can’t take my eyes off’ the mucosa
  Su Hyun Park, Sang Hyoung Park
  The Korean Journal of Internal Medicine.2022; 37(3): 551.     CrossRef
• Fecal S100A12 is associated with future hospitalization and step-up of medical treatment in patients with Crohn’s disease in clinical remission: a pilot study
  Sun-Ho Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
  Intestinal Research.2022; 20(2): 203.     CrossRef
• Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn’s Disease Recurrence
  Jongwook Yu, Hye Kyung Hyun, Jihye Park, Eun Ae Kang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon
  Gut and Liver.2022; 16(3): 414.     CrossRef
• Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests
  José María Paredes, Tomás Ripollés, Ángela Algarra, Rafael Diaz, Nadia Moreno, Patricia Latorre, María Jesús Martínez, Pilar Llopis, Antonio López, Eduardo Moreno-Osset
  Intestinal Research.2022; 20(3): 361.     CrossRef
• Radiation Exposure among Patients with Inflammatory Bowel Disease: A Single-Medical-Center Retrospective Analysis in Taiwan
  Chen-Ta Yang, Hsu-Heng Yen, Yang-Yuan Chen, Pei-Yuan Su, Siou-Ping Huang
  Journal of Clinical Medicine.2022; 11(17): 5050.     CrossRef
• Capsule endoscopy in Crohn's disease surveillance: A monocentric, retrospective analysis in Italy
  Carlo Calabrese, Dania Gelli, Fernando Rizzello, Paolo Gionchetti, Rafael Torrejon Torres, Rhodri Saunders, Jason Davis
  Frontiers in Medical Technology.2022;[Epub]     CrossRef
• Risk factors and prognostic value of acute severe lower gastrointestinal bleeding in Crohn’s disease
  Jiyoung Yoon, Dae Sung Kim, Ye-Jee Kim, Jin Wook Lee, Seung Wook Hong, Ha Won Hwang, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang
  World Journal of Gastroenterology.2021; 27(19): 2353.     CrossRef
• Is Paradigm for the Role of Balloon-Assisted Enteroscopy Changing in Crohn’s Disease?
  Yoo Jin Lee
  Gut and Liver.2021; 15(3): 325.     CrossRef
• Epithelial Regeneration Ability of Crohn’s Disease Assessed Using Patient-Derived Intestinal Organoids
  Chansu Lee, Sung-Noh Hong, Eun-Ran Kim, Dong-Kyung Chang, Young-Ho Kim
  International Journal of Molecular Sciences.2021; 22(11): 6013.     CrossRef
• Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease
  Shana Rakowsky, Adam S. Cheifetz, Konstantinos Papamichael
  Alimentary Pharmacology & Therapeutics.2021; 54(8): 1085.     CrossRef
• Another Piece of Evidence for Early Administration of Biologics in Children with Crohn's Disease Who Start as an Inflammatory Phenotype
  Hyuk Yoon
  Gut and Liver.2021; 15(6): 791.     CrossRef
• Capsule Endoscopy in Inflammatory Bowel Disease: When? To Whom?
  Soo-Young Na, Yun-Jeong Lim
  Diagnostics.2021; 11(12): 2240.     CrossRef

Citations

Citations to this article as recorded by  

• Combining mechanistic modeling with machine learning as a strategy to predict inflammatory bowel disease clinical scores
  Jaehee V. Shim, Markus Rehberg, Britta Wagenhuber, Piet H. van der Graaf, Douglas W. Chung
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021
  Hiroshi Nakase, Motohiro Esaki, Fumihito Hirai, Taku Kobayashi, Katsuyoshi Matsuoka, Minoru Matsuura, Makoto Naganuma, Masayuki Saruta, Kiichiro Tsuchiya, Motoi Uchino, Kenji Watanabe, Tadakazu Hisamatsu, Akira Andoh, Shigeki Bamba, Motohiro Esaki, Mikihi
  Journal of Gastroenterology.2023; 58(4): 313.     CrossRef
• Mucosal concentrations of N‐acetyl‐5‐aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine
  Tomohiro Fukuda, Makoto Naganuma, Kaoru Takabayashi, Yuya Hagihara, Shun Tanemoto, Ena Nomura, Yusuke Yoshimatsu, Shinya Sugimoto, Kosaku Nanki, Shinta Mizuno, Yohei Mikami, Kayoko Fukuhara, Tomohisa Sujino, Makoto Mutaguchi, Nagamu Inoue, Haruhiko Ogata,
  Journal of Gastroenterology and Hepatology.2020; 35(11): 1878.     CrossRef
• Clinical management for small bowel of Crohn’s disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesion
  Kenji Watanabe
  Intestinal Research.2020; 18(4): 347.     CrossRef

Citations

Citations to this article as recorded by  

• Partial Enteral Nutrition in the Management of Crohn’s Disease: A Systematic Review and Meta-Analysis
  Aleksandra Jatkowska, Bernadette White, Konstantinos Gkikas, John Paul Seenan, Jonathan MacDonald, Konstantinos Gerasimidis
  Journal of Crohn's and Colitis.2025;[Epub]     CrossRef
• Patient experiences with and adherence to Crohn’s disease exclusion diet in Dutch Crohn’s disease patients: a cohort study
  Fleur T. R. Wijers, Suzanne M. C. van Zundert, Charlotte M. Verburgt, Nikki van der Kruk, Johan E. Van Limbergen, Nicolette J. Wierdsma
  Therapeutic Advances in Gastroenterology.2025;[Epub]     CrossRef
• Nutrition and dietary therapy in paediatric inflammatory bowel disease
  Konstantinos Gerasimidis
  Clinical Nutrition ESPEN.2025; 67: 233.     CrossRef
• Pancreatic Enzyme Replacement Therapy Improves Exclusive Enteral Nutrition Related Diarrhea in Crohn's Disease: A Prospective Randomized Trial
  Jian Kang, Jing Wang, Juan Su, Wei Wang, Yueyue Lu, Zhishun Tang, Liping Zou, Anning Yin, Jiao Li, Haixia Ren, Qian Zhou, Huipeng Wan, Ping An
  United European Gastroenterology Journal.2025;[Epub]     CrossRef
• Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn’s disease
  Sisi Zhou, Zeyu Huang, Wenjing Hou, Yiting Lin, Jing Yu
  Inflammation Research.2024; 73(2): 199.     CrossRef
• Role of diet in prevention versus treatment of Crohn’s disease and ulcerative colitis
  Emma P Halmos, Lihi Godny, Julie Vanderstappen, Chen Sarbagili-Shabat, Vaios Svolos
  Frontline Gastroenterology.2024; : flgastro-2023-102417.     CrossRef
• Immunoregulatory Effects of Elemental Diet and Its Ingredient, Tryptophan, via Activation of the Aryl Hydrocarbon Receptor in Mice
  Atsuhito Kubota, Shungo Imai, Ryoichi Aoyagi, Wataru Murase, Masaru Terasaki, Mitsuru Sugawara, Yoh Takekuma, Hiroyuki Kojima
  International Journal of Molecular Sciences.2024; 25(6): 3448.     CrossRef
• Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A multicenter study
  Wei Wang, Anning Yin, Jing Wang, Jiao Li, Jingyun Cheng, Jian Kang, Yaqing Xu, Yueyue Lu, Yuanping Yang, Juan Su, Qian Zhou, Ya Liu, Zhishun Tang, Haixia Ren, Weiwei Li, Weiguo Dong, Baoping Yu, Ping An
  Clinical Nutrition.2024; 43(6): 1291.     CrossRef
• It’s Time to Change Tack in IBD Treatment
  Marcel A. Behr, Ildiko Mehes, Charles N. Bernstein
  Gastroenterology.2024; 167(6): 1065.     CrossRef
• "Out of the box� new therapeutic strategies for Crohn�s disease: moving beyond biologics
  Ignacio Catalán-Serra, Pret Ricanek, Tore Grimstad
  Revista Española de Enfermedades Digestivas.2022;[Epub]     CrossRef
• Nutritional Therapy Strategies in Pediatric Crohn’s Disease
  Charlotte M. Verburgt, Mohammed Ghiboub, Marc A. Benninga, Wouter J. de Jonge, Johan E. Van Limbergen
  Nutrients.2021; 13(1): 212.     CrossRef
• Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
  Hiroshi Nakase, Motoi Uchino, Shinichiro Shinzaki, Minoru Matsuura, Katsuyoshi Matsuoka, Taku Kobayashi, Masayuki Saruta, Fumihito Hirai, Keisuke Hata, Sakiko Hiraoka, Motohiro Esaki, Ken Sugimoto, Toshimitsu Fuji, Kenji Watanabe, Shiro Nakamura, Nagamu I
  Journal of Gastroenterology.2021; 56(6): 489.     CrossRef
• Diet and nutrition in the management of inflammatory bowel disease
  Pabitra Sahu, Saurabh Kedia, Vineet Ahuja, Rakesh K. Tandon
  Indian Journal of Gastroenterology.2021; 40(3): 253.     CrossRef
• Nutritional Aspects of Pediatric Gastrointestinal Diseases
  Teresa Di Chio, Christiane Sokollik, Diego G. Peroni, Lara Hart, Giacomo Simonetti, Franziska Righini-Grunder, Osvaldo Borrelli
  Nutrients.2021; 13(6): 2109.     CrossRef
• Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
  Sanchit Sharma, Arti Gupta, Saurabh Kedia, Samagra Agarwal, Namrata Singh, Sandeep Goyal, Saransh Jain, Vipin Gupta, Pabitra Sahu, Sudheer Kumar Vuyyuru, Bhaskar Kante, Raju Sharma, Rajesh Panwar, Peush Sahni, Govind Makharia, Vineet Ahuja
  Intestinal Research.2021; 19(3): 291.     CrossRef
• Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease
  Lara Hart, Charlotte M. Verburgt, Eytan Wine, Mary Zachos, Alisha Poppen, Mallory Chavannes, Johan Van Limbergen, Nikhil Pai
  Nutrients.2021; 14(1): 4.     CrossRef
• Efficacy of enteral nutrition in patients with Crohn’s disease on maintenance anti-TNF-alpha antibody therapy: a meta-analysis
  Fumihito Hirai, Teruyuki Takeda, Yasumichi Takada, Masahiro Kishi, Tsuyoshi Beppu, Noritaka Takatsu, Masaki Miyaoka, Takashi Hisabe, Kenshi Yao, Tosiharu Ueki
  Journal of Gastroenterology.2020; 55(2): 133.     CrossRef
• Inflammatory Bowel Disease in Japan-Is It Similar to or Different from Westerns?-
  Shinji Okabayashi, Taku Kobayashi, Toshifumi Hibi
  Journal of the Anus, Rectum and Colon.2020; 4(1): 1.     CrossRef
• Exclusive enteral nutrition for induction of remission in anti-tumor necrosis factor refractory adult Crohn’s disease: the Indian experience
  Ajit Sood, Arshdeep Singh, Ritu Sudhakar, Vandana Midha, Ramit Mahajan, Varun Mehta, Yogesh Kumar Gupta, Kirandeep Kaur
  Intestinal Research.2020; 18(2): 184.     CrossRef
• Enteral nutrition in the biologic era: learn from yesterday, live for today, hope for tomorrow
  Tadakazu Hisamatsu
  Intestinal Research.2020; 18(2): 139.     CrossRef
• Half-Elemental Diet Shifts the Human Intestinal Bacterial Compositions and Metabolites: A Pilot Study with Healthy Individuals
  Jun Miyoshi, Daisuke Saito, Mio Nakamura, Miki Miura, Tatsuya Mitsui, Toru Kudo, Shinnosuke Murakami, Minoru Matsuura, Tadakazu Hisamatsu
  Gastroenterology Research and Practice.2020; 2020: 1.     CrossRef
• Fool me once… treatment exposure to achieve remission in pediatric IBD
  Johan E. Van Limbergen, Bart G. P. Koot, J. Peter de Winter
  European Journal of Pediatrics.2020; 179(12): 1921.     CrossRef
• Bases for the Adequate Development of Nutritional Recommendations for Patients with Inflammatory Bowel Disease
  Esteban Sáez-González, Beatriz Mateos, Pedro López-Muñoz, Marisa Iborra, Inés Moret, Pilar Nos, Belén Beltrán
  Nutrients.2019; 11(5): 1062.     CrossRef

Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disease of the gastrointestinal tract, with increasing prevalence worldwide. IBD Ahead is an international educational program that aims to explore questions commonly raised by clinicians about various areas of IBD care and to consolidate available published evidence and expert opinion into a consensus for the optimization of IBD management. Given differences in the epidemiology, clinical and genetic characteristics, management, and prognosis of IBD between patients in Japan and the rest of the world, this statement was formulated as the result of literature reviews and discussions among Japanese experts as part of the IBD Ahead program to consolidate statements of factors for disease prognosis in IBD. Evidence levels were assigned to summary statements in the following categories: disease progression in CD and UC; surgery, hospitalization, intestinal failure, and permanent stoma in CD; acute severe UC; colectomy in UC; and colorectal carcinoma and dysplasia in IBD. The goal is that this statement can aid in the optimization of the treatment strategy for Japanese patients with IBD and help identify high-risk patients that require early intervention, to provide a better long-term prognosis in these patients.

Citations

Citations to this article as recorded by  

• Precision medicine in inflammatory bowel diseases
  Ashwin N. Ananthakrishnan
  Intestinal Research.2024; 22(1): 8.     CrossRef
• Impact of Concomitant Prescriptions and Lifestyle Factors on the Initial Course of Newly Diagnosed Inflammatory Bowel Disease
  Hiromu Morikubo, Takayoshi Nagahama, Katsuhiko Nagai, Hajime Yamazaki, Taku Kobayashi
  Inflammatory Intestinal Diseases.2024; 9(1): 260.     CrossRef
• A Retrospective Cohort Study of Clinical Features and Treatment Patterns With Ustekinumab in Patients With Crohn Disease Utilizing a Health Care Database in Japan
  Yanfang Liu, Choo Hua Goh, Hong Qiu, Kuan-Chih Huang, Hsingwen Chung, Carine Saadoun
  Annals of Pharmacotherapy.2023; 57(9): 1053.     CrossRef
• Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis
  Kunio Asonuma, Taku Kobayashi, Masaru Nakano, Shintaro Sagami, Hiroki Kiyohara, Mao Matsubayashi, Hiromu Morikubo, Yusuke Miyatani, Shinji Okabayashi, Hajime Yamazaki, Yuichiro Kuroki, Toshifumi Hibi
  Inflammatory Bowel Diseases.2022; 28(2): 200.     CrossRef
• Intestinal cancer in patients with Crohn's disease: A systematic review and meta‐analysis
  Motoi Uchino, Hiroki Ikeuchi, Keisuke Hata, Tomohiro Minagawa, Yuki Horio, Ryuichi Kuwahara, Shiro Nakamura, Kenji Watanabe, Masayuki Saruta, Toshimitsu Fujii, Taku Kobayashi, Ken Sugimoto, Fumihito Hirai, Motohiro Esaki, Sakiko Hiraoka, Katsuyoshi Matsuo
  Journal of Gastroenterology and Hepatology.2021; 36(2): 329.     CrossRef
• MR-enterography in Crohn’s disease: what MRE mural parameters are associated to one-year therapeutic management outcome?
  Pier Paolo Mainenti, Fabiana Castiglione, Antonio Rispo, Ettore Laccetti, Salvatore Guarino, Valeria Romeo, Anna Testa, Leonardo Pace, Simone Maurea
  The British Journal of Radiology.2021;[Epub]     CrossRef
• Incidence and Outcomes of Perianal Disease in an Asian Population with Crohn’s Disease: A Nationwide Population-Based Study
  Eun Mi Song, Ho-Su Lee, Ye-Jee Kim, Eun Hye Oh, Nam Seok Ham, Jeongseok Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Jong Lyul Lee, Yong Sik Yoon, Chang Sik Yu, Suk-Kyun Yang
  Digestive Diseases and Sciences.2020; 65(4): 1189.     CrossRef
• Passion fruit (Passiflora edulis) leaf aqueous extract ameliorates intestinal epithelial barrier dysfunction and reverts inflammatory parameters in Caco-2 cells monolayer
  Mônica Cristina Lopes do Carmo, Isabela Mateus Martins, Ana Elisa Ramos Magalhães, Mário Roberto Maróstica Júnior, Juliana Alves Macedo
  Food Research International.2020; 133: 109162.     CrossRef
• Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study
  Toshifumi Hibi, Satoshi Motoya, Toshifumi Ashida, Souken Sai, Yukinori Sameshima, Shiro Nakamura, Atsuo Maemoto, Masahiro Nii, Barbara A Sullivan, Robert A. Gasser Jr, Yasuo Suzuki
  Intestinal Research.2019; 17(3): 375.     CrossRef